92 related articles for article (PubMed ID: 9555007)
1. Laminin inhibits Abeta42 fibril formation in vitro.
Monji A; Tashiro K; Yoshida I; Tashiro N
Brain Res; 1998 Mar; 788(1-2):187-90. PubMed ID: 9555007
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of laminin 1 and synthetic peptides deduced from the sequence in the laminin alpha1 chain on Abeta40 fibril formation in vitro.
Monji A; Tashiro K; Hayashi Y; Yoshida I; Tashiro N
Neurosci Lett; 1998 Jul; 251(1):65-8. PubMed ID: 9714466
[TBL] [Abstract][Full Text] [Related]
3. Laminin inhibits both Abeta40 and Abeta42 fibril formation but does not affect Abeta40 or Abeta42-induced cytotoxicity in PC12 cells.
Monji A; Tashiro K; Yoshida I; Kaname H; Hayashi Y; Matsuda K; Tashiro N
Neurosci Lett; 1999 May; 266(2):85-8. PubMed ID: 10353333
[TBL] [Abstract][Full Text] [Related]
4. Laminin inhibits A beta 40 fibril formation promoted by apolipoprotein E4 in vitro.
Monji A; Tashiro K; Yoshida I; Hayashi Y; Tashiro N
Brain Res; 1998 Jun; 796(1-2):171-5. PubMed ID: 9689467
[TBL] [Abstract][Full Text] [Related]
5. Entactin-induced inhibition of human amyloid beta-protein fibril formation in vitro.
Kiuchi Y; Isobe Y; Fukushima K
Neurosci Lett; 2001 Jun; 305(2):119-22. PubMed ID: 11376898
[TBL] [Abstract][Full Text] [Related]
6. Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils.
Bronfman FC; Alvarez A; Morgan C; Inestrosa NC
Amyloid; 1998 Mar; 5(1):16-23. PubMed ID: 9547001
[TBL] [Abstract][Full Text] [Related]
7. Laminin inhibits amyloid-beta-peptide fibrillation.
Bronfman FC; Garrido J; Alvarez A; Morgan C; Inestrosa NC
Neurosci Lett; 1996 Nov; 218(3):201-3. PubMed ID: 8945763
[TBL] [Abstract][Full Text] [Related]
8. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
9. Disassembly of amyloid beta-protein fibril by basement membrane components.
Kiuchi Y; Isobe Y; Fukushima K; Kimura M
Life Sci; 2002 Apr; 70(20):2421-31. PubMed ID: 12150206
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
11. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
12. Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40.
Koppaka V; Paul C; Murray IV; Axelsen PH
J Biol Chem; 2003 Sep; 278(38):36277-84. PubMed ID: 12821671
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
14. Bacoside-A, an Indian Traditional-Medicine Substance, Inhibits β-Amyloid Cytotoxicity, Fibrillation, and Membrane Interactions.
Malishev R; Shaham-Niv S; Nandi S; Kolusheva S; Gazit E; Jelinek R
ACS Chem Neurosci; 2017 Apr; 8(4):884-891. PubMed ID: 28094495
[TBL] [Abstract][Full Text] [Related]
15. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
Oren O; Banerjee V; Taube R; Papo N
Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
[TBL] [Abstract][Full Text] [Related]
16. Probing the mechanism of inhibition of amyloid-β(1-42)-induced neurotoxicity by the chaperonin GroEL.
Wälti MA; Steiner J; Meng F; Chung HS; Louis JM; Ghirlando R; Tugarinov V; Nath A; Clore GM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11924-E11932. PubMed ID: 30509980
[TBL] [Abstract][Full Text] [Related]
17. Anti-amyloidogenic activity of tetracyclines: studies in vitro.
Forloni G; Colombo L; Girola L; Tagliavini F; Salmona M
FEBS Lett; 2001 Jan; 487(3):404-7. PubMed ID: 11163366
[TBL] [Abstract][Full Text] [Related]
18. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
19. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice.
Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K
J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049
[TBL] [Abstract][Full Text] [Related]
20. Type IV collagen prevents amyloid beta-protein fibril formation.
Kiuchi Y; Isobe Y; Fukushima K
Life Sci; 2002 Feb; 70(13):1555-64. PubMed ID: 11895106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
